Pathway
|
Osteoarthritis
|
|
Skin Aging
|
|
MTHFR Activity Regulation
|
|
Dopamine Receptors Signaling
|
|
Thrombopoietin Receptors Signaling in Platelet Maturation
|
|
Toll-like Receptors Act through MYD88-TIRAP Signaling
|
|
TLR4 Signaling in Leukocytes
|
|
Plasmin Effects in Inflammation
|
|
Scavenger Receptors in Platelet Activation
|
|
Toll-like Receptors in Sterile Inflammation
|
|
Basophil Activation
|
|
Eosinophil Survival by Cytokine Signaling
|
|
AXL Receptor Inhibits Macrophages and Dendritic Cells Function
|
|
Neutrophil Recruitment and Priming
|
|
Negative Acute Phase Proteins Synthesis
|
|
Positive Acute Phase Proteins Synthesis
|
|
Vascular Endothelial Cell Activation by Cytokines
|
|
Vascular Endothelial Cell Activation by Growth Factors
|
|
Nociception Expression Targets Signaling
|
|
EDNRA/B -> Vascular Motility
|
|
ADRA1A -> IL6 Production
|
|
CNR1/2 -> IL1B/2/4/6/10 Production
|
|
DRD2 Expression Targets
|
|
PTGER2/3 -> Inflammation-Related Expression Targets
|
|
Circadian Clock Genes in Suprachiasmatic Nuclei Neurons
|
|
Cardiomyocyte Dysfunction
|
|
Scavenger Receptor OLR1 in Inflammation Related Endothelial Dysfunction
|
|
Dendritic Cells Function in Atherosclerosis
|
|
Dilated Cardiomyopathy
|
|
Myocardial Remodeling
|
|
Myocardial Infarction
|
|
Inflammatory Reaction in Acne Vulgaris
|
|
Mast-Cells Activation in Atopic Dermatitis
|
|
IL17 Signaling in Psoriasis
|
|
Dendritic Cells Function in Psoriasis
|
|
Mesangial Cell Dysfunction in Diabetic Nephropathy
|
|
Insulin Resistance in Myocytes Induced by Obesity
|
|
Insulin Resistance in Hepatocytes
|
|
beta-Cell Destruction through Cytokines in Diabetes Mellitus
|
|
GNRH Signaling Impairment in Hypogonadotrophic Hypogonadism
|
|
OipA Signaling in Helicobacter Pylori Infection
|
|
Dendritic Cell Function in Ulcerative Colitis
|
|
Antiphospholipid Antibodies in Endothelial Cell
|
|
B-Cell Acute Lymphoblastic Leukemia
|
|
B-Cell Chronic Lymphocytic Leukemia
|
|
Chronic Myeloid Leukemia
|
|
Follicular Lymphoma
|
|
Osteoclast Activation in Multiple Myeloma
|
|
Multiple Myeloma
|
|
Antiphospholipid Antibodies and Endothelial Cell Interaction
|
|
T-Cell Acute Lymphoblastic Leukemia
|
|
Hepatocellular Carcinoma
|
|
Growth Factor Signaling in Hepatocellular Carcinoma
|
|
Proteins Involved in Pancreatic Cancer
|
|
Pancreatic Ductal Carcinoma
|
|
Growth Factor Signaling in Pancreatic Neoplasms
|
|
Mucin Production in Goblet Airway Epithelial Cells
|
|
CFTR Facilitates Oxidative Stress in Airway Epithelium in CF
|
|
Airway Epithelial Cell Dysfunction
|
|
Osteoclast Activation in Gout
|
|
Neutrophil Recruitment in Sinovium in Gout
|
|
Monocytes Function in Gout
|
|
TNF and IL1B Induce Metalloproteinase Synthesis in Osteoarthritis
|
|
Dendritic Cell Dysfunction in Psoriatic Arthritis
|
|
Synovial Fibroblast Activation in Psoriatic Arthritis
|
|
Keratinocyte Activation in Psoriatic Arthritis
|
|
Osteoclast Activation in Rheumatoid Arthritis
|
|
Synovial Fibroblast Activation by Citokines in Rheumatoid Arthritis
|
|
TLR2 Induced Synovial Fibroblast Activation in Rheumatoid Arthritis
|
|
Autocrine Cytokine/Chemokine Loops in Systemic Scleroderma
|
|
Skin Fibrosis
|
|
CCR5 Signaling in Macrophages
|
|
Majeed Syndrome
|
|
IL6 Promotes Inflammation in Muscular Dystrophies
|
|
Osteoclast Activation in Postmenopause
|
|
Glioma Invasion Signaling
|
|
Growth Factor Signaling in Neuroblastoma
|
|
Neuroblastoma
|
|
WNT Signaling in Breast Cancer
|
|
ESR1/ERBB Positive Luminal Breast Cancer
|
|
ESR1 Signaling in Breast Cancer
|
|
Endometrial Cancer
|
|
Endometrioid Endometrial Cancer
|
|
Proteins Involved in Endometrial Cancer
|
|
Clear Cell Endometrial Cancer and Papillary Serous Endometrial Cancer
|
|
Angiogenesis in Endometriosis
|
|
Proteins Involved in High-Grade Serous Ovarian Carcinoma
|
|
Endometrioid Ovarian Carcinoma
|
|
Proteins Involved in Endometrioid Ovarian Carcinoma
|
|
Clear Cell Ovarian Carcinoma
|
|
Proteins Involved in Mucinous Ovarian Carcinoma
|
|
High-Grade Serous Ovarian Carcinoma
|
|
Low-Grade Serous Ovarian Carcinoma
|
|
Proteins Involved in Low-Grade Serous Ovarian Carcinoma
|
|
Ovarian Cancer
|
|
Proteins Involved in Clear Cell Ovarian Carcinoma
|
|
Mucinous Ovarian Carcinoma
|
|
Subepithelial Fibroblasts in Middle Ear Cholesteatoma
|
|
HPV E5 Regulates EDNRA and EGFR Signaling Pathway in Keratinocytes
|
|
Androgen Receptor/Akt Signaling
|
|
Steroids Induced Cataract
|
|
VEGFA in Neovascular Glaucoma
|
|
Cytokines Trigger Otitis Media
|
|
Immune System Role in Otitis Media
|
|
Alveolar Macrophages Dysfunction in COPD
|
|
T-Cell Cytotoxic Activation
|
|
Mucin Hyperproduction in Goblet and Mucous Cells
|
|
WNT Signaling in Cystic Kidney Disease
|
|
Polycystins Mutation Effects in Cystic Kidney Disease
|
|
Plasmin Role in Glomerulonephritis
|
|
Endothelial Cell Dysfunction in Glomerulonephritis
|
|
Mesangial Cell Dysfunction in Glomerulonephritis
|
|
Interstitial Fibroblasts in Pyelonephritis
|
|
Apoptosis of Renal Tubule Epithelial Cell in Pyelonephritis
|
|
Endothelial Cell Dysfunction in Pyelonephritis
|
|
ANGPT1 -> CREB/CREBBP Expression Targets
|
|
ANGPT2 -> AP-1/CREBBP/MYC Expression Targets
|
|
AREG -> CREB/CREBBP Expression Targets
|
|
AREG -> AP-1 Expression Targets
|
|
Dopamine/Gi Expression Targets
|
|
BTC -> AP-1/ATF/CREB Expression Targets
|
|
Frizzled Receptors -> ARRB1/ARRB2 non-Canonical Signaling
|
|
AGTR1 -> ARRB1/ARRB2 Signaling
|
|
Sialophorin -> CTNNB/MYC/TP53 Signaling
|
|
CD72 -> NF-kB Expression Targets
|
|
CD8 -> NF-kB Expression Targets
|
|
CD80 -> NFATC Expression Targets
|
|
CD86 -> NFATC Expression Targets
|
|
EGF -> AP-1/ATF Expression Targets
|
|
EGF -> CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
EGF -> TP53 Expression Targets
|
|
EGFR/ERBB2 -> TP53 Signaling
|
|
EGFR -> AP-1/ATF2 Signaling
|
|
EGFR -> AP-1/CREB/ELK/SRF/MYC Signaling
|
|
EREG -> CREB Expression Target
|
|
EREG -> AP-1/ATF Expression Targets
|
|
Erythropoietin -> AP-1/MYC/CREB Expression Targets
|
|
F2 -> AP-1/CREB/ELK/SRF/SP1 Expression Targets
|
|
PLG -> AP-1/CREB/ELK/SRF/SP1 Expression Targets
|
|
FGF9 -> AP-1/CREB/MYC Expression Targets
|
|
FGF10 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FGF1 -> AP-1/CREB/ELK/SRF/MYC Expression Targets
|
|
FGF8 -> AP-1/CREB/MYC Expression Targets
|
|
FGF18 -> AP-1/CREB Expression Targets
|
|
FGF4 -> AP-1/MYC Expression Targets
|
|
FGF7 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FGF2 -> AP-1/CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
FGFR -> AP-1/CREB/CREBBP/ELK/SRF/MYC Signaling
|
|
FrizzledR -> JUN/PAX2 Signaling
|
|
HBEGF -> AP-1/ATF Expression Targets
|
|
HBEGF -> TP53 Expression Targets
|
|
HBEGF -> CREB/MYC Expression Targets
|
|
HGF -> AP-1/CREB/ELK/SRF/MYC Expression Targets
|
|
HGFR -> AP-1/CREB/MYC Signaling
|
|
RAS/RAF/MAPK Signaling Activation in Cancer
|
|
RAS/RAF/MAPK Signaling Activation by Blocking of Tumor Suppressors
|
|
TGFB Signaling activation by Blocking of Tumor Suppressors
|
|
Apoptosis Block by Death Receptor Signaling in Cancer
|
|
Apoptosis Evasion in Cancer: Overview
|
|
VEGFA Dependent Angiogenesis in Cancer
|
|
Inhibition of THBS1 Activates Angiogenesis in Cancer
|
|
VEGF Independent Angiogenesis in Cancer
|
|
TGFB Family in Epithelial to Mesenchymal Transition in Cancer
|
|
FibronectinR -> NF-kB Signaling
|
|
FibronectinR -> AP-1/ELK/SRF/SREBF Signaling
|
|
Fibronectin Expression Targets
|
|
CTGF -> AP-1/CREB/MYC Expression Targets
|
|
IL1R -> STAT3 Signaling
|
|
IL16-> ATF/CREB/CREBBP Expression Target
|
|
PAF/Gq -> AP-1/ATF1/CREB/ERK/SRF Expression Targets
|
|
Dronabinol/Anandamide Expression Targets
|
|
S1P Expression Targets
|
|
NRG1 -> CREB/CREBBP/ELK/SRF/MYC Expression Targets
|
|
NRG1 -> TP53 Expression Target
|
|
NRG1 -> AP-1/ATF Expression Targets
|
|
NGF -> SMAD3/NF-kB Expression Targets
|
|
NGF -> AP-1/TP53/MYC Expression Targets
|
|
BDNF Expression Targets
|
|
NTF3 Expression Targets
|
|
NTF4 Expression Targets
|
|
NGF -> CREB/CEBPB/MEF2A Expression Targets
|
|
NOTCH -> TCF3 Signaling
|
|
NOTCH Expression Targets
|
|
PDGFB -> AP-1/CREB/MYC Expression Target
|
|
PDGFC -> CREB Expression Target
|
|
PDGFD -> AP-1 Expression Targets
|
|
PDGF -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
PDGFR -> AP-1/MYC Signaling
|
|
AVP/Gs -> CREB/ELK/SRF/AP-1/EGR Expression Targets
|
|
GNRH1 Expression Targets
|
|
GNRH2 Expression Targets
|
|
EDN1 Expression Targets
|
|
EDN3 Expression Targets
|
|
AVP/Gq -> CREB/ELK/SRF/AP-1/EGR Expression Targets
|
|
PDCD1 -> ATF/CREB/CREBBP Expression Targets
|
|
AngiopoietinR -> AP-1 Signaling
|
|
GDNF -> HSF1 Signaling
|
|
EphrinB -> MAPK/JUN/FOS Signaling
|
|
NTRK -> AP-1/CREB/ELK/SRF/MYC/SMAD3/TP53 Signaling
|
|
GAS6 -> AP-1/CREB Expression Targets
|
|
FIGF -> AP-1 Expression Target
|
|
KITLG -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
GDNF -> HSF1 Expression Targets
|
|
CSF1 -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
PGF -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
FLT3LG -> AP-1/CREB/CREBBP Expression Targets
|
|
TGFBR -> AP-1 Signaling
|
|
TGFBR -> CREB/ELK-SRF Signaling
|
|
TGFBR -> ATF/GADD/MAX/TP53 Signaling
|
|
TGFBR -> MEF/MYOD/MYOG Signaling
|
|
TNF-alpha/TNFRSF1A Signaling
|
|
JNK/MAPK Signaling
|
|
TGF-beta Signaling
|
|
P38 MAPK/MAPK14 Signaling
|
|
AXL Receptor Tyrosine Kinase Signaling
|
|
PI3K/RAC1 Signaling
|
|
VEGF Signaling
|
|
EGFR Signaling
|
|
WNT Planar Cell Polarity (PCP) non-Canonical Signaling
|
|
TCR -> CREB/CREBBP/ATF Expression Targets
|
|
T-Cell Receptor -> ATF/CREB Signaling
|
|
TGFA -> TP53 Expression Targets
|
|
TGFA/AP-1/ATF Expression Targets
|
|
TGFA -> CREB/CREBBP/ELK-SRF/MYC Expression Targets
|
|
TGFB3-TGFBR2 Expression Targets
|
|
TGFB2-TGFBR2 Expression Targets
|
|
TGFB1-TGFBR2 Expression Targets
|
|
FASLG Expression Targets
|
|
TNFSF10 Expression Targets
|
|
LTA Expression Targets
|
|
TNFSF14 Expression Targets
|
|
TNF -> AP-1 Expression Targets
|
|
CD72 -> AP-1 Expression Targets
|
|
CD40LG -> NF-kB/ELK/SRF -> CREB/NFATC Expression Targets
|
|
TNFSF13 Expression Targets
|
|
TNFSF13B Expression Targets
|
|
TNF -> ELK-SRF Expression Targets
|
|
TNF -> CREB Expression Targets
|
|
TNF -> TP53/ATF Expression Targets
|
|
EDA Expression Targets
|
|
EctodysplasinR -> AP-1 Signaling
|
|
TNFR -> CREB/ELK-SRF Signaling
|
|
TNFR -> AP-1/ATF/TP53 Signaling
|
|
NGFR -> AP-1/CEBPB/CREB/ELK/SRF/TP53 Signaling
|
|
NGFR -> MEF Signaling
|
|
TNFRSF6 -> DDIT3 Signaling
|
|
TNFRSF6 -> HSF1 Signaling
|
|
TNFRSF1A -> AP-1/ATF/TP53 Signaling
|
|
TNFRSF1A -> CREB/ELK-SRF Signaling
|
|
Thrombopoietin -> SPI1 Expression Targets
|
|
Thrombopoietin -> AP-1/CREB/CREBBP/MYC Expression Targets
|
|
TLR4 -> AP-1 Expression Targets
|
|
TLR5 Expression Targets
|
|
TLR7 Expression Targets
|
|
TLR4 -> AP-1/EGR1/HIF1A Expression Targets
|
|
IL1B -> PGE2 Expression Targets
|
|
TLR1 -> 2/6 Expression Targets
|
|
IL1B Expression Targets
|
|
IL1A Expression Targets
|
|
TLR9 Expression Targets
|
|
TLR -> AP-1 Signaling
|
|
ROS in Angiotensin Mediated Cardiovascular Remodeling and Hypertrophy
|
|
VEGFA -> ATF/CREB/ELK-SRF Expression Targets
|
|
VEGFC -> ATF Expression Target
|
|
VEGFA -> AP-1/CREBBP/MYC Expression Targets
|
|
VEGFR -> AP-1/CREB/MYC Signaling
|
|
VEGFR -> ATF/CREB/ELK-SRF Signaling
|
|
WNT1 Expression Targets
|
|
WNT3A Expression Targets
|
|
WNT4 Expression Targets
|
|
WNT5A Expression Targets
|
|
WNT7A Expression Targets
|
|
1_Inflammation in keratinocytes in the pathology of acne
|
|
2_Acute phase initiation in atopic dermatitis
|
|
2_Interleukin-17 and interleukin-22 signaling in psoriasis
|
|
1_TNF and IL1B provoke ECM degradation in osteoarthritis
|
|
1_Osteoclast-mediated bone resorption in postmenopausal women
|
|
1_Formation of cysts in polycystic kidney disease
|
|
2_The role of endothelial cells in pyelonephritis
|
|
3_The role of interstitial fibroblasts in pyelonephritis
|
|
3_Mesangial cell dysfunction in glomerulonephritis
|
|
1_Disruption of luteinizing hormone and follicle-stimulating hormone secretion in PCOS
|
|
2_Pathogens stimulate mucins expression in the middle ear
|
|
3_Cardiomyocyte dysfunction unrelated to cell junctions in ARVD
|
|
2_Intestine epithelial cells drive immunological responses in ulcerative colitis
|
|
6_p12I Viral protein promotes T-cell activation in HTLV-1 infection
|
|
4_2_Insulin resistance: inflammation-related insulin resistance
|
|
4_3_Insulin resistance: FFA-related insulin resistance
|
|
2_Neuron and Schwann cell death
|
|
mapk1 protein modificators
|
|
Interleukin-17 and interleukin-22 signaling in psoriasis
|